カテゴリー： 世界, 医療/バイオ, LP Information

世界のプロスタサイクリン受容体作動薬市場予測 2023年-2029年

【英語タイトル】Global Prostacyclin Receptor Agonist Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC09140）・商品コード：LP23DC09140
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：94
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のプロスタサイクリン受容体作動薬市場」は、過去の販売実績から2022年の世界のプロスタサイクリン受容体作動薬の総販売量を検討し、2023年から2029年の予測されるプロスタサイクリン受容体作動薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のプロスタサイクリン受容体作動薬の市場規模を掲載し、XXX百万米ドル規模の世界のプロスタサイクリン受容体作動薬市場の詳細な分析を提供します。本インサイトレポートは、世界のプロスタサイクリン受容体作動薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のプロスタサイクリン受容体作動薬市場における各社の独自のポジションをより深く理解するために、プロスタサイクリン受容体作動薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のプロスタサイクリン受容体作動薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。プロスタサイクリン受容体作動薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。プロスタサイクリン受容体作動薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。プロスタサイクリン受容体作動薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

プロスタサイクリン受容体作動薬の世界主要メーカーとしては、United Therapeutics Corporation、 Pfizer、 Insmed Incorporated、 Gilead Sciences、 CRISPR Therapeutics、 Chiesi Farmaceutici、 Bayer AG、 Arena Pharmaceuticals、 Actelion Pharmaceuticalsなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のプロスタサイクリン受容体作動薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではプロスタサイクリン受容体作動薬市場をセグメンテーションし、種類別 (エポプロステノールナトリウム、トレプロスチニル、ベラプロスト)、用途別 (病院、製薬会社、研究所、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：エポプロステノールナトリウム、トレプロスチニル、ベラプロスト

・用途別区分：病院、製薬会社、研究所、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のプロスタサイクリン受容体作動薬市場の10年間の市場状況・展望は？
・世界および地域別に見たプロスタサイクリン受容体作動薬市場成長の要因は何か？
・プロスタサイクリン受容体作動薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・プロスタサイクリン受容体作動薬のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：プロスタサイクリン受容体作動薬の年間販売量2018-2029、地域別現状・将来分析
・プロスタサイクリン受容体作動薬の種類別セグメント：エポプロステノールナトリウム、トレプロスチニル、ベラプロスト
・プロスタサイクリン受容体作動薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・プロスタサイクリン受容体作動薬の用途別セグメント：病院、製薬会社、研究所、診療所、その他
・プロスタサイクリン受容体作動薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のプロスタサイクリン受容体作動薬市場
・企業別のグローバルプロスタサイクリン受容体作動薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別のプロスタサイクリン受容体作動薬の年間売上：2018-2023年の売上、市場シェア
・企業別のプロスタサイクリン受容体作動薬販売価格
・主要企業のプロスタサイクリン受容体作動薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

プロスタサイクリン受容体作動薬の地域別レビュー
・地域別のプロスタサイクリン受容体作動薬市場規模2018-2023：年間販売量、売上
・主要国別のプロスタサイクリン受容体作動薬市場規模2018-2023：年間販売量、売上
・南北アメリカのプロスタサイクリン受容体作動薬販売の成長
・アジア太平洋のプロスタサイクリン受容体作動薬販売の成長
・ヨーロッパのプロスタサイクリン受容体作動薬販売の成長
・中東・アフリカのプロスタサイクリン受容体作動薬販売の成長

南北アメリカ市場
・南北アメリカの国別のプロスタサイクリン受容体作動薬販売量、売上（2018-2023）
・南北アメリカのプロスタサイクリン受容体作動薬の種類別販売量
・南北アメリカのプロスタサイクリン受容体作動薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のプロスタサイクリン受容体作動薬販売量、売上（2018-2023）
・アジア太平洋のプロスタサイクリン受容体作動薬の種類別販売量
・アジア太平洋のプロスタサイクリン受容体作動薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のプロスタサイクリン受容体作動薬販売量、売上（2018-2023）
・ヨーロッパのプロスタサイクリン受容体作動薬の種類別販売量
・ヨーロッパのプロスタサイクリン受容体作動薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のプロスタサイクリン受容体作動薬販売量、売上（2018-2023）
・中東・アフリカのプロスタサイクリン受容体作動薬の種類別販売量
・中東・アフリカのプロスタサイクリン受容体作動薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・プロスタサイクリン受容体作動薬の製造コスト構造分析
・プロスタサイクリン受容体作動薬の製造プロセス分析
・プロスタサイクリン受容体作動薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・プロスタサイクリン受容体作動薬の主要なグローバル販売業者
・プロスタサイクリン受容体作動薬の主要なグローバル顧客

地域別のプロスタサイクリン受容体作動薬市場予測レビュー
・地域別のプロスタサイクリン受容体作動薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・プロスタサイクリン受容体作動薬の種類別市場規模予測
・プロスタサイクリン受容体作動薬の用途別市場規模予測

主要企業分析
United Therapeutics Corporation、 Pfizer、 Insmed Incorporated、 Gilead Sciences、 CRISPR Therapeutics、 Chiesi Farmaceutici、 Bayer AG、 Arena Pharmaceuticals、 Actelion Pharmaceuticals
・企業情報
・プロスタサイクリン受容体作動薬製品
・プロスタサイクリン受容体作動薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Prostacyclin Receptor Agonist market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Prostacyclin Receptor Agonist is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Prostacyclin Receptor Agonist is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Prostacyclin Receptor Agonist is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Prostacyclin Receptor Agonist players cover United Therapeutics Corporation, Pfizer, Insmed Incorporated, Gilead Sciences, CRISPR Therapeutics, Chiesi Farmaceutici, Bayer AG, Arena Pharmaceuticals and Actelion Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Prostacyclin Receptor Agonist Industry Forecast” looks at past sales and reviews total world Prostacyclin Receptor Agonist sales in 2022, providing a comprehensive analysis by region and market sector of projected Prostacyclin Receptor Agonist sales for 2023 through 2029. With Prostacyclin Receptor Agonist sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prostacyclin Receptor Agonist industry.
This Insight Report provides a comprehensive analysis of the global Prostacyclin Receptor Agonist landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prostacyclin Receptor Agonist portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prostacyclin Receptor Agonist market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prostacyclin Receptor Agonist and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prostacyclin Receptor Agonist.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostacyclin Receptor Agonist market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Epoprostenol Sodium
Treprostinil
Beraprost
Segmentation by application
Hospital
Pharmaceutical Company
Laboratory
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
United Therapeutics Corporation
Pfizer
Insmed Incorporated
Gilead Sciences
CRISPR Therapeutics
Chiesi Farmaceutici
Bayer AG
Arena Pharmaceuticals
Actelion Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Prostacyclin Receptor Agonist market?
What factors are driving Prostacyclin Receptor Agonist market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Prostacyclin Receptor Agonist market opportunities vary by end market size?
How does Prostacyclin Receptor Agonist break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prostacyclin Receptor Agonist Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Prostacyclin Receptor Agonist by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Prostacyclin Receptor Agonist by Country/Region, 2018, 2022 & 2029
2.2 Prostacyclin Receptor Agonist Segment by Type
2.2.1 Epoprostenol Sodium
2.2.2 Treprostinil
2.2.3 Beraprost
2.3 Prostacyclin Receptor Agonist Sales by Type
2.3.1 Global Prostacyclin Receptor Agonist Sales Market Share by Type (2018-2023)
2.3.2 Global Prostacyclin Receptor Agonist Revenue and Market Share by Type (2018-2023)
2.3.3 Global Prostacyclin Receptor Agonist Sale Price by Type (2018-2023)
2.4 Prostacyclin Receptor Agonist Segment by Application
2.4.1 Hospital
2.4.2 Pharmaceutical Company
2.4.3 Laboratory
2.4.4 Clinic
2.4.5 Others
2.5 Prostacyclin Receptor Agonist Sales by Application
2.5.1 Global Prostacyclin Receptor Agonist Sale Market Share by Application (2018-2023)
2.5.2 Global Prostacyclin Receptor Agonist Revenue and Market Share by Application (2018-2023)
2.5.3 Global Prostacyclin Receptor Agonist Sale Price by Application (2018-2023)
3 Global Prostacyclin Receptor Agonist by Company
3.1 Global Prostacyclin Receptor Agonist Breakdown Data by Company
3.1.1 Global Prostacyclin Receptor Agonist Annual Sales by Company (2018-2023)
3.1.2 Global Prostacyclin Receptor Agonist Sales Market Share by Company (2018-2023)
3.2 Global Prostacyclin Receptor Agonist Annual Revenue by Company (2018-2023)
3.2.1 Global Prostacyclin Receptor Agonist Revenue by Company (2018-2023)
3.2.2 Global Prostacyclin Receptor Agonist Revenue Market Share by Company (2018-2023)
3.3 Global Prostacyclin Receptor Agonist Sale Price by Company
3.4 Key Manufacturers Prostacyclin Receptor Agonist Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Prostacyclin Receptor Agonist Product Location Distribution
3.4.2 Players Prostacyclin Receptor Agonist Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Prostacyclin Receptor Agonist by Geographic Region
4.1 World Historic Prostacyclin Receptor Agonist Market Size by Geographic Region (2018-2023)
4.1.1 Global Prostacyclin Receptor Agonist Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Prostacyclin Receptor Agonist Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Prostacyclin Receptor Agonist Market Size by Country/Region (2018-2023)
4.2.1 Global Prostacyclin Receptor Agonist Annual Sales by Country/Region (2018-2023)
4.2.2 Global Prostacyclin Receptor Agonist Annual Revenue by Country/Region (2018-2023)
4.3 Americas Prostacyclin Receptor Agonist Sales Growth
4.4 APAC Prostacyclin Receptor Agonist Sales Growth
4.5 Europe Prostacyclin Receptor Agonist Sales Growth
4.6 Middle East & Africa Prostacyclin Receptor Agonist Sales Growth
5 Americas
5.1 Americas Prostacyclin Receptor Agonist Sales by Country
5.1.1 Americas Prostacyclin Receptor Agonist Sales by Country (2018-2023)
5.1.2 Americas Prostacyclin Receptor Agonist Revenue by Country (2018-2023)
5.2 Americas Prostacyclin Receptor Agonist Sales by Type
5.3 Americas Prostacyclin Receptor Agonist Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Prostacyclin Receptor Agonist Sales by Region
6.1.1 APAC Prostacyclin Receptor Agonist Sales by Region (2018-2023)
6.1.2 APAC Prostacyclin Receptor Agonist Revenue by Region (2018-2023)
6.2 APAC Prostacyclin Receptor Agonist Sales by Type
6.3 APAC Prostacyclin Receptor Agonist Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Prostacyclin Receptor Agonist by Country
7.1.1 Europe Prostacyclin Receptor Agonist Sales by Country (2018-2023)
7.1.2 Europe Prostacyclin Receptor Agonist Revenue by Country (2018-2023)
7.2 Europe Prostacyclin Receptor Agonist Sales by Type
7.3 Europe Prostacyclin Receptor Agonist Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Prostacyclin Receptor Agonist by Country
8.1.1 Middle East & Africa Prostacyclin Receptor Agonist Sales by Country (2018-2023)
8.1.2 Middle East & Africa Prostacyclin Receptor Agonist Revenue by Country (2018-2023)
8.2 Middle East & Africa Prostacyclin Receptor Agonist Sales by Type
8.3 Middle East & Africa Prostacyclin Receptor Agonist Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Prostacyclin Receptor Agonist
10.3 Manufacturing Process Analysis of Prostacyclin Receptor Agonist
10.4 Industry Chain Structure of Prostacyclin Receptor Agonist
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Prostacyclin Receptor Agonist Distributors
11.3 Prostacyclin Receptor Agonist Customer
12 World Forecast Review for Prostacyclin Receptor Agonist by Geographic Region
12.1 Global Prostacyclin Receptor Agonist Market Size Forecast by Region
12.1.1 Global Prostacyclin Receptor Agonist Forecast by Region (2024-2029)
12.1.2 Global Prostacyclin Receptor Agonist Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Prostacyclin Receptor Agonist Forecast by Type
12.7 Global Prostacyclin Receptor Agonist Forecast by Application
13 Key Players Analysis
13.1 United Therapeutics Corporation
13.1.1 United Therapeutics Corporation Company Information
13.1.2 United Therapeutics Corporation Prostacyclin Receptor Agonist Product Portfolios and Specifications
13.1.3 United Therapeutics Corporation Prostacyclin Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 United Therapeutics Corporation Main Business Overview
13.1.5 United Therapeutics Corporation Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Prostacyclin Receptor Agonist Product Portfolios and Specifications
13.2.3 Pfizer Prostacyclin Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Insmed Incorporated
13.3.1 Insmed Incorporated Company Information
13.3.2 Insmed Incorporated Prostacyclin Receptor Agonist Product Portfolios and Specifications
13.3.3 Insmed Incorporated Prostacyclin Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Insmed Incorporated Main Business Overview
13.3.5 Insmed Incorporated Latest Developments
13.4 Gilead Sciences
13.4.1 Gilead Sciences Company Information
13.4.2 Gilead Sciences Prostacyclin Receptor Agonist Product Portfolios and Specifications
13.4.3 Gilead Sciences Prostacyclin Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Gilead Sciences Main Business Overview
13.4.5 Gilead Sciences Latest Developments
13.5 CRISPR Therapeutics
13.5.1 CRISPR Therapeutics Company Information
13.5.2 CRISPR Therapeutics Prostacyclin Receptor Agonist Product Portfolios and Specifications
13.5.3 CRISPR Therapeutics Prostacyclin Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CRISPR Therapeutics Main Business Overview
13.5.5 CRISPR Therapeutics Latest Developments
13.6 Chiesi Farmaceutici
13.6.1 Chiesi Farmaceutici Company Information
13.6.2 Chiesi Farmaceutici Prostacyclin Receptor Agonist Product Portfolios and Specifications
13.6.3 Chiesi Farmaceutici Prostacyclin Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Chiesi Farmaceutici Main Business Overview
13.6.5 Chiesi Farmaceutici Latest Developments
13.7 Bayer AG
13.7.1 Bayer AG Company Information
13.7.2 Bayer AG Prostacyclin Receptor Agonist Product Portfolios and Specifications
13.7.3 Bayer AG Prostacyclin Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bayer AG Main Business Overview
13.7.5 Bayer AG Latest Developments
13.8 Arena Pharmaceuticals
13.8.1 Arena Pharmaceuticals Company Information
13.8.2 Arena Pharmaceuticals Prostacyclin Receptor Agonist Product Portfolios and Specifications
13.8.3 Arena Pharmaceuticals Prostacyclin Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Arena Pharmaceuticals Main Business Overview
13.8.5 Arena Pharmaceuticals Latest Developments
13.9 Actelion Pharmaceuticals
13.9.1 Actelion Pharmaceuticals Company Information
13.9.2 Actelion Pharmaceuticals Prostacyclin Receptor Agonist Product Portfolios and Specifications
13.9.3 Actelion Pharmaceuticals Prostacyclin Receptor Agonist Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Actelion Pharmaceuticals Main Business Overview
13.9.5 Actelion Pharmaceuticals Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Prostacyclin Receptor Agonist Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Prostacyclin Receptor Agonist Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Epoprostenol Sodium
Table 4. Major Players of Treprostinil
Table 5. Major Players of Beraprost
Table 6. Global Prostacyclin Receptor Agonist Sales by Type (2018-2023) & (K Units)
Table 7. Global Prostacyclin Receptor Agonist Sales Market Share by Type (2018-2023)
Table 8. Global Prostacyclin Receptor Agonist Revenue by Type (2018-2023) & ($ million)
Table 9. Global Prostacyclin Receptor Agonist Revenue Market Share by Type (2018-2023)
Table 10. Global Prostacyclin Receptor Agonist Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Prostacyclin Receptor Agonist Sales by Application (2018-2023) & (K Units)
Table 12. Global Prostacyclin Receptor Agonist Sales Market Share by Application (2018-2023)
Table 13. Global Prostacyclin Receptor Agonist Revenue by Application (2018-2023)
Table 14. Global Prostacyclin Receptor Agonist Revenue Market Share by Application (2018-2023)
Table 15. Global Prostacyclin Receptor Agonist Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Prostacyclin Receptor Agonist Sales by Company (2018-2023) & (K Units)
Table 17. Global Prostacyclin Receptor Agonist Sales Market Share by Company (2018-2023)
Table 18. Global Prostacyclin Receptor Agonist Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Prostacyclin Receptor Agonist Revenue Market Share by Company (2018-2023)
Table 20. Global Prostacyclin Receptor Agonist Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Prostacyclin Receptor Agonist Producing Area Distribution and Sales Area
Table 22. Players Prostacyclin Receptor Agonist Products Offered
Table 23. Prostacyclin Receptor Agonist Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Prostacyclin Receptor Agonist Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Prostacyclin Receptor Agonist Sales Market Share Geographic Region (2018-2023)
Table 28. Global Prostacyclin Receptor Agonist Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Prostacyclin Receptor Agonist Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Prostacyclin Receptor Agonist Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Prostacyclin Receptor Agonist Sales Market Share by Country/Region (2018-2023)
Table 32. Global Prostacyclin Receptor Agonist Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Prostacyclin Receptor Agonist Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Prostacyclin Receptor Agonist Sales by Country (2018-2023) & (K Units)
Table 35. Americas Prostacyclin Receptor Agonist Sales Market Share by Country (2018-2023)
Table 36. Americas Prostacyclin Receptor Agonist Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Prostacyclin Receptor Agonist Revenue Market Share by Country (2018-2023)
Table 38. Americas Prostacyclin Receptor Agonist Sales by Type (2018-2023) & (K Units)
Table 39. Americas Prostacyclin Receptor Agonist Sales by Application (2018-2023) & (K Units)
Table 40. APAC Prostacyclin Receptor Agonist Sales by Region (2018-2023) & (K Units)
Table 41. APAC Prostacyclin Receptor Agonist Sales Market Share by Region (2018-2023)
Table 42. APAC Prostacyclin Receptor Agonist Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Prostacyclin Receptor Agonist Revenue Market Share by Region (2018-2023)
Table 44. APAC Prostacyclin Receptor Agonist Sales by Type (2018-2023) & (K Units)
Table 45. APAC Prostacyclin Receptor Agonist Sales by Application (2018-2023) & (K Units)
Table 46. Europe Prostacyclin Receptor Agonist Sales by Country (2018-2023) & (K Units)
Table 47. Europe Prostacyclin Receptor Agonist Sales Market Share by Country (2018-2023)
Table 48. Europe Prostacyclin Receptor Agonist Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Prostacyclin Receptor Agonist Revenue Market Share by Country (2018-2023)
Table 50. Europe Prostacyclin Receptor Agonist Sales by Type (2018-2023) & (K Units)
Table 51. Europe Prostacyclin Receptor Agonist Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Prostacyclin Receptor Agonist Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Prostacyclin Receptor Agonist Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Prostacyclin Receptor Agonist Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Prostacyclin Receptor Agonist Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Prostacyclin Receptor Agonist Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Prostacyclin Receptor Agonist Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Prostacyclin Receptor Agonist
Table 59. Key Market Challenges & Risks of Prostacyclin Receptor Agonist
Table 60. Key Industry Trends of Prostacyclin Receptor Agonist
Table 61. Prostacyclin Receptor Agonist Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Prostacyclin Receptor Agonist Distributors List
Table 64. Prostacyclin Receptor Agonist Customer List
Table 65. Global Prostacyclin Receptor Agonist Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Prostacyclin Receptor Agonist Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Prostacyclin Receptor Agonist Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Prostacyclin Receptor Agonist Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Prostacyclin Receptor Agonist Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Prostacyclin Receptor Agonist Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Prostacyclin Receptor Agonist Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Prostacyclin Receptor Agonist Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Prostacyclin Receptor Agonist Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Prostacyclin Receptor Agonist Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Prostacyclin Receptor Agonist Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Prostacyclin Receptor Agonist Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Prostacyclin Receptor Agonist Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Prostacyclin Receptor Agonist Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. United Therapeutics Corporation Basic Information, Prostacyclin Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 80. United Therapeutics Corporation Prostacyclin Receptor Agonist Product Portfolios and Specifications
Table 81. United Therapeutics Corporation Prostacyclin Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. United Therapeutics Corporation Main Business
Table 83. United Therapeutics Corporation Latest Developments
Table 84. Pfizer Basic Information, Prostacyclin Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 85. Pfizer Prostacyclin Receptor Agonist Product Portfolios and Specifications
Table 86. Pfizer Prostacyclin Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Pfizer Main Business
Table 88. Pfizer Latest Developments
Table 89. Insmed Incorporated Basic Information, Prostacyclin Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 90. Insmed Incorporated Prostacyclin Receptor Agonist Product Portfolios and Specifications
Table 91. Insmed Incorporated Prostacyclin Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Insmed Incorporated Main Business
Table 93. Insmed Incorporated Latest Developments
Table 94. Gilead Sciences Basic Information, Prostacyclin Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 95. Gilead Sciences Prostacyclin Receptor Agonist Product Portfolios and Specifications
Table 96. Gilead Sciences Prostacyclin Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Gilead Sciences Main Business
Table 98. Gilead Sciences Latest Developments
Table 99. CRISPR Therapeutics Basic Information, Prostacyclin Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 100. CRISPR Therapeutics Prostacyclin Receptor Agonist Product Portfolios and Specifications
Table 101. CRISPR Therapeutics Prostacyclin Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. CRISPR Therapeutics Main Business
Table 103. CRISPR Therapeutics Latest Developments
Table 104. Chiesi Farmaceutici Basic Information, Prostacyclin Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 105. Chiesi Farmaceutici Prostacyclin Receptor Agonist Product Portfolios and Specifications
Table 106. Chiesi Farmaceutici Prostacyclin Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Chiesi Farmaceutici Main Business
Table 108. Chiesi Farmaceutici Latest Developments
Table 109. Bayer AG Basic Information, Prostacyclin Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 110. Bayer AG Prostacyclin Receptor Agonist Product Portfolios and Specifications
Table 111. Bayer AG Prostacyclin Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Bayer AG Main Business
Table 113. Bayer AG Latest Developments
Table 114. Arena Pharmaceuticals Basic Information, Prostacyclin Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 115. Arena Pharmaceuticals Prostacyclin Receptor Agonist Product Portfolios and Specifications
Table 116. Arena Pharmaceuticals Prostacyclin Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Arena Pharmaceuticals Main Business
Table 118. Arena Pharmaceuticals Latest Developments
Table 119. Actelion Pharmaceuticals Basic Information, Prostacyclin Receptor Agonist Manufacturing Base, Sales Area and Its Competitors
Table 120. Actelion Pharmaceuticals Prostacyclin Receptor Agonist Product Portfolios and Specifications
Table 121. Actelion Pharmaceuticals Prostacyclin Receptor Agonist Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Actelion Pharmaceuticals Main Business
Table 123. Actelion Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Prostacyclin Receptor Agonist
Figure 2. Prostacyclin Receptor Agonist Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Prostacyclin Receptor Agonist Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Prostacyclin Receptor Agonist Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Prostacyclin Receptor Agonist Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Epoprostenol Sodium
Figure 10. Product Picture of Treprostinil
Figure 11. Product Picture of Beraprost
Figure 12. Global Prostacyclin Receptor Agonist Sales Market Share by Type in 2022
Figure 13. Global Prostacyclin Receptor Agonist Revenue Market Share by Type (2018-2023)
Figure 14. Prostacyclin Receptor Agonist Consumed in Hospital
Figure 15. Global Prostacyclin Receptor Agonist Market: Hospital (2018-2023) & (K Units)
Figure 16. Prostacyclin Receptor Agonist Consumed in Pharmaceutical Company
Figure 17. Global Prostacyclin Receptor Agonist Market: Pharmaceutical Company (2018-2023) & (K Units)
Figure 18. Prostacyclin Receptor Agonist Consumed in Laboratory
Figure 19. Global Prostacyclin Receptor Agonist Market: Laboratory (2018-2023) & (K Units)
Figure 20. Prostacyclin Receptor Agonist Consumed in Clinic
Figure 21. Global Prostacyclin Receptor Agonist Market: Clinic (2018-2023) & (K Units)
Figure 22. Prostacyclin Receptor Agonist Consumed in Others
Figure 23. Global Prostacyclin Receptor Agonist Market: Others (2018-2023) & (K Units)
Figure 24. Global Prostacyclin Receptor Agonist Sales Market Share by Application (2022)
Figure 25. Global Prostacyclin Receptor Agonist Revenue Market Share by Application in 2022
Figure 26. Prostacyclin Receptor Agonist Sales Market by Company in 2022 (K Units)
Figure 27. Global Prostacyclin Receptor Agonist Sales Market Share by Company in 2022
Figure 28. Prostacyclin Receptor Agonist Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Prostacyclin Receptor Agonist Revenue Market Share by Company in 2022
Figure 30. Global Prostacyclin Receptor Agonist Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Prostacyclin Receptor Agonist Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Prostacyclin Receptor Agonist Sales 2018-2023 (K Units)
Figure 33. Americas Prostacyclin Receptor Agonist Revenue 2018-2023 ($ Millions)
Figure 34. APAC Prostacyclin Receptor Agonist Sales 2018-2023 (K Units)
Figure 35. APAC Prostacyclin Receptor Agonist Revenue 2018-2023 ($ Millions)
Figure 36. Europe Prostacyclin Receptor Agonist Sales 2018-2023 (K Units)
Figure 37. Europe Prostacyclin Receptor Agonist Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Prostacyclin Receptor Agonist Sales 2018-2023 (K Units)
Figure 39. Middle East & Africa Prostacyclin Receptor Agonist Revenue 2018-2023 ($ Millions)
Figure 40. Americas Prostacyclin Receptor Agonist Sales Market Share by Country in 2022
Figure 41. Americas Prostacyclin Receptor Agonist Revenue Market Share by Country in 2022
Figure 42. Americas Prostacyclin Receptor Agonist Sales Market Share by Type (2018-2023)
Figure 43. Americas Prostacyclin Receptor Agonist Sales Market Share by Application (2018-2023)
Figure 44. United States Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Prostacyclin Receptor Agonist Sales Market Share by Region in 2022
Figure 49. APAC Prostacyclin Receptor Agonist Revenue Market Share by Regions in 2022
Figure 50. APAC Prostacyclin Receptor Agonist Sales Market Share by Type (2018-2023)
Figure 51. APAC Prostacyclin Receptor Agonist Sales Market Share by Application (2018-2023)
Figure 52. China Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Prostacyclin Receptor Agonist Sales Market Share by Country in 2022
Figure 60. Europe Prostacyclin Receptor Agonist Revenue Market Share by Country in 2022
Figure 61. Europe Prostacyclin Receptor Agonist Sales Market Share by Type (2018-2023)
Figure 62. Europe Prostacyclin Receptor Agonist Sales Market Share by Application (2018-2023)
Figure 63. Germany Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Prostacyclin Receptor Agonist Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Prostacyclin Receptor Agonist Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Prostacyclin Receptor Agonist Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Prostacyclin Receptor Agonist Sales Market Share by Application (2018-2023)
Figure 72. Egypt Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Prostacyclin Receptor Agonist Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Prostacyclin Receptor Agonist in 2022
Figure 78. Manufacturing Process Analysis of Prostacyclin Receptor Agonist
Figure 79. Industry Chain Structure of Prostacyclin Receptor Agonist
Figure 80. Channels of Distribution
Figure 81. Global Prostacyclin Receptor Agonist Sales Market Forecast by Region (2024-2029)
Figure 82. Global Prostacyclin Receptor Agonist Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Prostacyclin Receptor Agonist Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Prostacyclin Receptor Agonist Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Prostacyclin Receptor Agonist Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Prostacyclin Receptor Agonist Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のプロスタサイクリン受容体作動薬市場予測 2023年-2029年] (コード：LP23DC09140)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のプロスタサイクリン受容体作動薬市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のトロンボポエチン受容体アゴニスト市場2022年：ペプチド剤、低分子剤
  • 世界のプロゲステロン受容体アゴニスト市場2022年：天然プロゲステロン受容体作動薬、合成プロゲステロン受容体作動薬
  • 世界のベンゾジアゼピン受容体作動薬市場予測 2023年-2029年
  • 世界のメラトニン受容体アゴニスト市場予測 2023年-2029年
  • 世界の不眠症用オレキシン受容体拮抗薬市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆